Long-term outcomes among drug-dependent mothers treated in women-only versus mixed-gender programs.

Women-Centered Drug Treatment Services and Need in the United States, 2002-2009. Am J Public Health (2015) 0.93

GENDER-RESPONSIVE DRUG COURT TREATMENT: A Randomized Controlled Trial. Crim Justice Behav (2012) 0.86

Mortality among substance-using mothers in California: a 10-year prospective study. Addiction (2011) 0.85

Developmental timing of first drug treatment and 10-year patterns of drug use. J Subst Abuse Treat (2012) 0.84

Explaining long-term outcomes among drug dependent mothers treated in women-only versus mixed-gender programs. J Subst Abuse Treat (2013) 0.83

Perceived neighborhood safety, recovery capital, and successful outcomes among mothers 10 years after substance abuse treatment. Subst Use Misuse (2014) 0.83

Hispanic parenting women in women-only versus mixed-gender drug treatment: a 10-year prospective study. Addict Behav (2012) 0.75

Psychiatric Co-Morbidities in Pregnant Women with Opioid Use Disorders: Prevalence, Impact, and Implications for Treatment. Curr Addict Rep (2017) 0.75

Heterogeneity of Mental Health Service Utilization and High Mental Health Service Use Among Women Eight Years After Initiating Substance Use Disorder Treatment. J Subst Abuse Treat (2015) 0.75

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med (1998) 32.43

The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat (1992) 29.45

Estimating causal effects from large data sets using propensity scores. Ann Intern Med (1997) 19.65

Matching using estimated propensity scores: relating theory to practice. Biometrics (1996) 6.73

Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alcohol Depend (2006) 5.64

Effectiveness of substance abuse treatment programming for women: a review. Am J Drug Alcohol Abuse (2003) 2.54

Using propensity scores to adjust for selection bias when assessing the effectiveness of Alcoholics Anonymous in observational studies. Drug Alcohol Depend (2009) 1.54

Sex differences in addict careers. 1. Initiation of use. Am J Drug Alcohol Abuse (1987) 1.53

Predictors of prison-based treatment outcomes: a comparison of men and women participants. Am J Drug Alcohol Abuse (2006) 1.51

Origins and consequences of child neglect in substance abuse families. Clin Psychol Rev (2002) 1.48

Gender comparisons of drug abuse treatment outcomes and predictors. Drug Alcohol Depend (2003) 1.48

Childhood trauma and women's health outcomes in a California prison population. Am J Public Health (2006) 1.45

Drug abuse's smallest victims: in utero drug exposure. Forensic Sci Int (2002) 1.32

Substance use, health, and mental health: problems and service utilization among incarcerated women. Int J Offender Ther Comp Criminol (2003) 1.32

Program variation in treatment outcomes among women in residential drug treatment. Eval Rev (2000) 1.30

Cross-system data linkage for treatment outcome evaluation: lessons learned from the California Treatment Outcome Project. Eval Program Plann (2008) 1.27

Substance abuse treatment for women: changes in the settings where women received treatment and types of services provided, 1987-1998. J Behav Health Serv Res (2004) 1.25

A randomized experimental study of gender-responsive substance abuse treatment for women in prison. J Subst Abuse Treat (2009) 1.24

Predictors of treatment outcomes in men and women admitted to a therapeutic community. Am J Drug Alcohol Abuse (2000) 1.21

A review of recent findings on substance abuse treatment for pregnant women. J Subst Abuse Treat (1999) 1.21

Characteristics of women-only and mixed-gender drug abuse treatment programs. J Subst Abuse Treat (1999) 1.21

Perinatal substance abuse treatment. Findings from focus groups with clients and providers. J Subst Abuse Treat (1999) 1.19

Women-only and mixed-gender drug abuse treatment programs: service needs, utilization and outcomes. Drug Alcohol Depend (2006) 1.13

Identifying pregnant women at risk for early attrition from substance abuse treatment. J Subst Abuse Treat (2004) 1.10

Using administrative data for longitudinal substance abuse research. J Behav Health Serv Res (2008) 1.08

Women in residential drug treatment: differences by program type and pregnancy. J Health Care Poor Underserved (1999) 1.04

Are special treatment facilities for female alcoholics needed? A controlled 2-year follow-up study from a specialized female unit (EWA) versus a mixed male/female treatment facility. Alcohol Clin Exp Res (1989) 1.04

The relative effectiveness of women-only and mixed-gender treatment for substance-abusing women. J Subst Abuse Treat (2011) 1.04

Does gender-specific substance abuse treatment for women promote continuity of care? J Subst Abuse Treat (2006) 1.02

Retaining cocaine-abusing women in a therapeutic community: the effect of a child live-in program. Am J Public Health (1995) 1.00

Women's programs versus mixed-gender day treatment: results from a randomized study. Addiction (2005) 0.99

Effectiveness of long-term residential substance abuse treatment for women: findings from three national studies. Am J Drug Alcohol Abuse (2004) 0.93

Prison-based treatment for drug-dependent women offenders: treatment versus no treatment. J Psychoactive Drugs (2006) 0.93

The impact of prenatal drug exposure on the neonate. Obstet Gynecol Clin North Am (1998) 0.88

Residential substance abuse treatment for pregnant and postpartum women and their children: treatment and policy implications. Child Welfare (2001) 0.86

Pregnant women in women-only and mixed-gender substance abuse treatment programs: a comparison of client characteristics and program services. J Behav Health Serv Res (2006) 0.85

Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express (2012) 5.60

Detection of macular ganglion cell loss in glaucoma by Fourier-domain optical coherence tomography. Ophthalmology (2009) 4.44

Ultrahigh speed 1050nm swept source/Fourier domain OCT retinal and anterior segment imaging at 100,000 to 400,000 axial scans per second. Opt Express (2010) 4.10

In vivo total retinal blood flow measurement by Fourier domain Doppler optical coherence tomography. J Biomed Opt (2007) 2.86

Comparison of optical coherence tomography and ultrasound biomicroscopy for detection of narrow anterior chamber angles. Arch Ophthalmol (2005) 2.80

A pilot study of Fourier-domain optical coherence tomography of retinal dystrophy patients. Am J Ophthalmol (2008) 2.78

Anterior chamber width measurement by high-speed optical coherence tomography. Ophthalmology (2005) 2.77

Mapping of macular substructures with optical coherence tomography for glaucoma diagnosis. Ophthalmology (2007) 2.77

Relationship between drug treatment services, retention, and outcomes. Psychiatr Serv (2004) 2.33

Use of lung transplantation survival models to refine patient selection in cystic fibrosis. Am J Respir Crit Care Med (2005) 2.29

Quantitative OCT angiography of optic nerve head blood flow. Biomed Opt Express (2012) 2.29

Corneal pachymetry mapping with high-speed optical coherence tomography. Ophthalmology (2006) 2.24

Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial. Addiction (2013) 2.23

Lay patient navigator program implementation for equal access to cancer care and clinical trials: essential steps and initial challenges. Cancer (2006) 2.14

Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"? Health Serv Res (2006) 2.14

Laser in situ keratomileusis for myopia and astigmatism: safety and efficacy: a report by the American Academy of Ophthalmology. Ophthalmology (2002) 2.14

Total retinal blood flow measurement with ultrahigh speed swept source/Fourier domain OCT. Biomed Opt Express (2011) 2.13

Retinal assessment using optical coherence tomography. Prog Retin Eye Res (2006) 2.05

High-speed optical coherence tomography of corneal opacities. Ophthalmology (2007) 2.02

Retinal blood flow measurement by circumpapillary Fourier domain Doppler optical coherence tomography. J Biomed Opt (2009) 1.97

Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis. Hum Mol Genet (2003) 1.96

Access, interest, and attitudes toward electronic communication for health care among patients in the medical safety net. J Gen Intern Med (2013) 1.90

Clinical and research applications of anterior segment optical coherence tomography - a review. Clin Experiment Ophthalmol (2008) 1.80

Group index of the human cornea at 1.3-microm wavelength obtained in vitro by optical coherence domain reflectometry. Opt Lett (2004) 1.73

Pilot study of optical coherence tomography measurement of retinal blood flow in retinal and optic nerve diseases. Invest Ophthalmol Vis Sci (2011) 1.71

Treatment outcomes among women and men methamphetamine abusers in California. J Subst Abuse Treat (2005) 1.69

The complex exogenous RNA spectra in human plasma: an interface with human gut biota? PLoS One (2012) 1.68

Corneal epithelial thickness mapping by Fourier-domain optical coherence tomography in normal and keratoconic eyes. Ophthalmology (2012) 1.67

Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study. Addiction (2012) 1.62

Blood flow velocity quantification using split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Biomed Opt Express (2013) 1.61

Phase-sensitive swept-source optical coherence tomography imaging of the human retina with a vertical cavity surface-emitting laser light source. Opt Lett (2013) 1.60

Trajectories of heroin addiction: growth mixture modeling results based on a 33-year follow-up study. Eval Rev (2007) 1.57

Commentary on Degenhardt et al. (2014): Regional variation in the global burden of disease attributable to opioid dependence-where do the data come from and does population size matter? Addiction (2014) 1.51

Portrait of Candida albicans adherence regulators. PLoS Pathog (2012) 1.51

A 12-year follow-up of a treated cocaine-dependent sample. J Subst Abuse Treat (2006) 1.50

Retinal blood flow detection in diabetic patients by Doppler Fourier domain optical coherence tomography. Opt Express (2009) 1.49

Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital. J Clin Microbiol (2010) 1.49

Gender comparisons of drug abuse treatment outcomes and predictors. Drug Alcohol Depend (2003) 1.48

Reproducibility of anterior chamber angle measurements obtained with anterior segment optical coherence tomography. Invest Ophthalmol Vis Sci (2007) 1.46

Regulation of the cytoplasmic quality control protein degradation pathway by BAG2. J Biol Chem (2005) 1.46

Polydrug use and implications for longitudinal research: ten-year trajectories for heroin, cocaine, and methamphetamine users. Drug Alcohol Depend (2008) 1.43

Keratoconus diagnosis with optical coherence tomography pachymetry mapping. Ophthalmology (2008) 1.43

Optimization of the split-spectrum amplitude-decorrelation angiography algorithm on a spectral optical coherence tomography system. Opt Lett (2015) 1.42

Risk factors for intraoperative epithelial defect in laser in-situ keratomileusis. Am J Ophthalmol (2002) 1.41

Evidence-based nursing practice. II: Advanced concepts for WOC nursing practice. J Wound Ostomy Continence Nurs (2004) 1.39

Cancer risk behaviors and screening rates among homeless adults in Los Angeles County. Cancer Epidemiol Biomarkers Prev (2002) 1.35

Corneal power measurement with Fourier-domain optical coherence tomography. J Cataract Refract Surg (2010) 1.35

Pachymetric mapping with Fourier-domain optical coherence tomography. J Cataract Refract Surg (2010) 1.35

A longitudinal study of LASIK flap and stromal thickness with high-speed optical coherence tomography. Ophthalmology (2007) 1.35

Contrasting trajectories of heroin, cocaine, and methamphetamine use. J Addict Dis (2008) 1.34

OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES OF DIABETIC RETINOPATHY. Retina (2015) 1.31

Measurement of central corneal thickness by high-resolution Scheimpflug imaging, Fourier-domain optical coherence tomography and ultrasound pachymetry. Acta Ophthalmol (2010) 1.29

Gold(I)-catalyzed cyclizations of silyl enol ethers: application to the synthesis of (+)-lycopladine A. Angew Chem Int Ed Engl (2006) 1.28

Measuring total corneal power before and after laser in situ keratomileusis with high-speed optical coherence tomography. J Cataract Refract Surg (2006) 1.28

Identification of carbapenem-resistant klebsiella pneumoniae harboring KPC enzymes in New Jersey. Microb Drug Resist (2007) 1.27

Cross-system data linkage for treatment outcome evaluation: lessons learned from the California Treatment Outcome Project. Eval Program Plann (2008) 1.27

Combining nerve fiber layer parameters to optimize glaucoma diagnosis with optical coherence tomography. Ophthalmology (2008) 1.27

Optical coherence tomography imaging of the anterior chamber angle. Ophthalmol Clin North Am (2005) 1.26

Relationship among visual field, blood flow, and neural structure measurements in glaucoma. Invest Ophthalmol Vis Sci (2012) 1.25

Correlates of treatment follow-up difficulty. Subst Use Misuse (2002) 1.23

High-speed optical coherence tomography of laser iridotomy. Am J Ophthalmol (2005) 1.23

Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China. Addiction (2011) 1.22

Measurement of absolute flow velocity vector using dual-angle, delay-encoded Doppler optical coherence tomography. Opt Lett (2007) 1.21

Performance of creatinine-based estimates of GFR in kidney transplant recipients: a systematic review. Am J Kidney Dis (2008) 1.20

Anterior segment optical coherence tomography for imaging the anterior chamber after laser peripheral iridotomy. Am J Ophthalmol (2006) 1.20

Parafoveal retinal vascular response to pattern visual stimulation assessed with OCT angiography. PLoS One (2013) 1.20

Patterns of ganglion cell complex and nerve fiber layer loss in nonarteritic ischemic optic neuropathy by Fourier-domain optical coherence tomography. Invest Ophthalmol Vis Sci (2012) 1.19

A feasibility study of optical coherence tomography for guiding deep brain probes. J Neurosci Methods (2006) 1.19

Impact of California's Proposition 36 on the drug treatment system: treatment capacity and displacement. Am J Public Health (2006) 1.19

Comparing the dynamic course of heroin, cocaine, and methamphetamine use over 10 years. Addict Behav (2008) 1.18

Self-report of Longitudinal Substance Use: A Comparison of the UCLA Natural History Interview and the Addiction Severity Index. J Drug Issues (2010) 1.18

Changes in angle configuration after phacoemulsification measured by anterior segment optical coherence tomography. J Glaucoma (2008) 1.18

Towards measurement of the Healthy Ageing Phenotype in lifestyle-based intervention studies. Maturitas (2013) 1.17

Trajectories of HIV risk behavior from age 15 to 25 in the national longitudinal survey of youth sample. J Youth Adolesc (2008) 1.17

Urinary microRNA profiling in the nephropathy of type 1 diabetes. PLoS One (2013) 1.16

DETECTION OF NONEXUDATIVE CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION WITH OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Retina (2015) 1.15

A system dynamics model for planning cardiovascular disease interventions. Am J Public Health (2010) 1.14

Long-term course of opioid addiction. Harv Rev Psychiatry (2015) 1.14

Optical coherence tomography assessment of angle anatomy changes after cataract surgery. Am J Ophthalmol (2007) 1.12

Wavefront-guided LASIK for the correction of primary myopia and astigmatism a report by the American Academy of Ophthalmology. Ophthalmology (2008) 1.12

The effects of an exercise program in leukemia patients. Integr Cancer Ther (2009) 1.12

Regional correlation among ganglion cell complex, nerve fiber layer, and visual field loss in glaucoma. Invest Ophthalmol Vis Sci (2013) 1.12

An intraocular lens power calculation formula based on optical coherence tomography: a pilot study. J Refract Surg (2010) 1.07

Swept source/Fourier domain polarization sensitive optical coherence tomography with a passive polarization delay unit. Opt Express (2012) 1.07

LASIK for hyperopia, hyperopic astigmatism, and mixed astigmatism: a report by the American Academy of Ophthalmology. Ophthalmology (2004) 1.06

Changes in anterior segment morphology in response to illumination and after laser iridotomy in Asian eyes: an anterior segment OCT study. Br J Ophthalmol (2007) 1.05

Automated detection of clinically significant macular edema by grid scanning optical coherence tomography. Ophthalmology (2006) 1.05

Improving clinical trial design in acute lung injury. Crit Care Med (2003) 1.04

Characteristics of keratoconus and pellucid marginal degeneration in mean curvature maps. Am J Ophthalmol (2005) 1.03

Ethnic differences in utilization of drug treatment services and outcomes among Proposition 36 offenders in California. J Subst Abuse Treat (2007) 0.99

Reproducibility of tear meniscus measurement by Fourier-domain optical coherence tomography: a pilot study. Ophthalmic Surg Lasers Imaging (2009) 0.99

A qualitative examination of the positive and negative consequences associated with going tobacco-free in substance abuse treatment: the NY State experience. Nicotine Tob Res (2012) 0.99

A randomized controlled trial of group cognitive-behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophr Res (2009) 0.98